162 related articles for article (PubMed ID: 22682081)
1. Functional protease profiling with reporter peptides in serum specimens of colorectal cancer patients: demonstration of its routine diagnostic applicability.
Findeisen P; Costina V; Yepes D; Hofheinz R; Neumaier M
J Exp Clin Cancer Res; 2012 Jun; 31(1):56. PubMed ID: 22682081
[TBL] [Abstract][Full Text] [Related]
2. Substrate optimization and clinical validation of reporter peptides for MS-based protease profiling in serum specimens: a new approach for diagnosis of malignant disease.
Yepes D; Jacob A; Dauber M; Costina V; Hofheinz R; Neumaier M; Findeisen P
Int J Oncol; 2011 Jul; 39(1):145-54. PubMed ID: 21503574
[TBL] [Abstract][Full Text] [Related]
3. Endoprotease profiling with double-tagged peptide substrates: a new diagnostic approach in oncology.
Peccerella T; Lukan N; Hofheinz R; Schadendorf D; Kostrezewa M; Neumaier M; Findeisen P
Clin Chem; 2010 Feb; 56(2):272-80. PubMed ID: 20110451
[TBL] [Abstract][Full Text] [Related]
4. Multiplex profiling of tumor-associated proteolytic activity in serum of colorectal cancer patients.
Yepes D; Costina V; Pilz LR; Hofheinz R; Neumaier M; Findeisen P
Proteomics Clin Appl; 2014 Jun; 8(5-6):308-16. PubMed ID: 24616428
[TBL] [Abstract][Full Text] [Related]
5. Functional protease profiling for laboratory based diagnosis of invasive aspergillosis.
Sabbagh B; Costina V; Buchheidt D; Reinwald M; Neumaier M; Findeisen P
Int J Oncol; 2015 Jul; 47(1):143-50. PubMed ID: 25954923
[TBL] [Abstract][Full Text] [Related]
6. Spiking of serum specimens with exogenous reporter peptides for mass spectrometry based protease profiling as diagnostic tool.
Findeisen P; Peccerella T; Post S; Wenz F; Neumaier M
Rapid Commun Mass Spectrom; 2008 Apr; 22(8):1223-9. PubMed ID: 18348224
[TBL] [Abstract][Full Text] [Related]
7. MS-based monitoring of proteolytic decay of synthetic reporter peptides for quality control of plasma and serum specimens.
Findeisen P; Thumfart JO; Costina V; Hofheinz R; Neumaier M
Am J Clin Pathol; 2013 Sep; 140(3):314-23. PubMed ID: 23955449
[TBL] [Abstract][Full Text] [Related]
8. Functional protease profiling for diagnosis of malignant disease.
Findeisen P; Neumaier M
Proteomics Clin Appl; 2012 Jan; 6(1-2):60-78. PubMed ID: 22213637
[TBL] [Abstract][Full Text] [Related]
9. Colon tumour secretopeptidome: insights into endogenous proteolytic cleavage events in the colon tumour microenvironment.
Greening DW; Kapp EA; Ji H; Speed TP; Simpson RJ
Biochim Biophys Acta; 2013 Nov; 1834(11):2396-407. PubMed ID: 23684732
[TBL] [Abstract][Full Text] [Related]
10. Alterations of the Plasma Peptidome Profiling in Colorectal Cancer Progression.
Bedin C; Crotti S; Ragazzi E; Pucciarelli S; Agatea L; Tasciotti E; Ferrari M; Traldi P; Rizzolio F; Giordano A; Nitti D; Agostini M
J Cell Physiol; 2016 Apr; 231(4):915-25. PubMed ID: 26379225
[TBL] [Abstract][Full Text] [Related]
11. Specificity of metabolic colorectal cancer biomarkers in serum through effect size.
Di Giovanni N; Meuwis MA; Louis E; Focant JF
Metabolomics; 2020 Aug; 16(8):88. PubMed ID: 32789702
[TBL] [Abstract][Full Text] [Related]
12. Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection.
Ritchie SA; Ahiahonu PW; Jayasinghe D; Heath D; Liu J; Lu Y; Jin W; Kavianpour A; Yamazaki Y; Khan AM; Hossain M; Su-Myat KK; Wood PL; Krenitsky K; Takemasa I; Miyake M; Sekimoto M; Monden M; Matsubara H; Nomura F; Goodenowe DB
BMC Med; 2010 Feb; 8():13. PubMed ID: 20156336
[TBL] [Abstract][Full Text] [Related]
13. High-Resolution Mass Spectrometry-Based Approaches for the Detection and Quantification of Peptidase Activity in Plasma.
Maffioli E; Jiang Z; Nonnis S; Negri A; Romeo V; Lietz CB; Hook V; Ristagno G; Baselli G; Kistler EB; Aletti F; O'Donoghue AJ; Tedeschi G
Molecules; 2020 Sep; 25(18):. PubMed ID: 32899982
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Proteomic Technologies for Blood-Based Detection of Colorectal Cancer.
Bhardwaj M; Terzer T; Schrotz-King P; Brenner H
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530402
[TBL] [Abstract][Full Text] [Related]
15. Characterization and identification of proteases secreted by Aspergillus fumigatus using free flow electrophoresis and MS.
Neustadt M; Costina V; Kupfahl C; Buchheidt D; Eckerskorn C; Neumaier M; Findeisen P
Electrophoresis; 2009 Jun; 30(12):2142-50. PubMed ID: 19582717
[TBL] [Abstract][Full Text] [Related]
16. Mass spectrometry based analytical quality assessment of serum and plasma specimens with patterns of endo- and exogenous peptides.
Findeisen P; Hemanna S; Maharjan RS; Mindt S; Costina V; Hofheinz R; Neumaier M
Clin Chem Lab Med; 2019 Apr; 57(5):668-678. PubMed ID: 30511923
[TBL] [Abstract][Full Text] [Related]
17. LC-MS/MS quantification of Zn-alpha2 glycoprotein: a potential serum biomarker for prostate cancer.
Bondar OP; Barnidge DR; Klee EW; Davis BJ; Klee GG
Clin Chem; 2007 Apr; 53(4):673-8. PubMed ID: 17317883
[TBL] [Abstract][Full Text] [Related]
18. Pre-analytical-related variability influencing serum peptide profiles demonstrated in a mass spectrometry-based search for colorectal and prostate cancer biomarkers.
Karczmarski J; Rubel T; Mikula M; Wolski J; Rutkowski A; Zagorowicz E; Dadlez M; Ostrowski J
Acta Biochim Pol; 2013; 60(3):417-25. PubMed ID: 24046818
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of protease activity in serum samples of prostate carcinoma patients with metastases.
Dekker LJ; Burgers PC; Charif H; van Rijswijk AL; Titulaer MK; Jenster G; Bischoff R; Bangma CH; Luider TM
Proteomics; 2010 Jun; 10(12):2348-58. PubMed ID: 20394078
[TBL] [Abstract][Full Text] [Related]
20. Serum microRNA signatures and metabolomics have high diagnostic value in colorectal cancer using two novel methods.
Liu HN; Liu TT; Wu H; Chen YJ; Tseng YJ; Yao C; Weng SQ; Dong L; Shen XZ
Cancer Sci; 2018 Apr; 109(4):1185-1194. PubMed ID: 29363233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
